Back to Search
Start Over
Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells.
- Source :
-
Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2015 Jul; Vol. 22 (7), pp. 688-96. Date of Electronic Publication: 2015 Apr 29. - Publication Year :
- 2015
-
Abstract
- Tuberculosis (TB) remains a global health problem, with vaccination being a necessary strategy for disease containment and elimination. A TB vaccine should be safe and immunogenic as well as efficacious in all affected populations, including HIV-infected individuals. We investigated the induction and maintenance of vaccine-induced memory CD4(+) T cells following vaccination with the subunit vaccine H1/IC31. H1/IC31 was inoculated twice on study days 0 and 56 among HIV-infected adults with CD4(+) lymphocyte counts of >350 cells/mm(3). Whole venous blood stimulation was conducted with the H1 protein, and memory CD4(+) T cells were analyzed using intracellular cytokine staining and polychromatic flow cytometry. We identified high responders, intermediate responders, and nonresponders based on detection of interleukin-2 (IL-2), tumor necrosis factor alpha (TNF-α), and gamma interferon (IFN-γ) expressing central (TCM) and effector memory CD4(+) T cells (TEM) 182 days after the first immunization. Amplicon-based transcript quantification using next-generation sequencing was performed to identify differentially expressed genes that correlated with vaccine-induced immune responses. Genes implicated in resolution of inflammation discriminated the responders from the nonresponders 3 days after the first inoculation. The volunteers with higher expression levels of genes involved in antiviral innate immunity at baseline showed impaired H1-specific TCM and TEM maintenance 6 months after vaccination. Our study showed that in HIV-infected volunteers, expression levels of genes involved in the antiviral innate immune response affected long-term maintenance of H1/IC31 vaccine-induced cellular immunity. (The clinical trial was registered in the Pan African Clinical Trials Registry [PACTR] with the identifier PACTR201105000289276.).<br /> (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Subjects :
- Adult
Cytokines metabolism
Female
Humans
Male
Middle Aged
Molecular Sequence Data
Sequence Analysis, DNA
Tuberculosis immunology
Tuberculosis Vaccines administration & dosage
Vaccines, Subunit administration & dosage
Vaccines, Subunit immunology
CD4-Positive T-Lymphocytes immunology
HIV Infections immunology
Immune Tolerance
Immunity, Innate
Immunologic Memory
Tuberculosis prevention & control
Tuberculosis Vaccines immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1556-679X
- Volume :
- 22
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Clinical and vaccine immunology : CVI
- Publication Type :
- Academic Journal
- Accession number :
- 25924764
- Full Text :
- https://doi.org/10.1128/CVI.00092-15